MedPath

Implications of Self-weighing During Weight Loss Treatment

Not Applicable
Conditions
Signs and Symptoms
Overweight and Obesity
Behavior, Eating
Interventions
Behavioral: Control Group (CG)
Behavioral: Intervention Group (IG)
Registration Number
NCT04032249
Lead Sponsor
Universidad de Córdoba
Brief Summary

This study aims to analyze the effectiveness of introducing behavioral elements in a weight loss program, in this case, comparing the difference between self-weighing versus not doing so.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
70
Inclusion Criteria
  • Having a IMC >25,
  • Being sedentary and
  • Have not been submitted to a restrictive diet in the 6 months preceding this study
Exclusion Criteria
  • Suffered from type 2 diabetes or renal conditions
  • Being pregnancy or attempt at pregnancy,
  • Undergoing antidepressant pharmacological treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control Group (CG)Control Group (CG)Education and modifying diet
Intervention Group (IG)Intervention Group (IG)Education, modifying diet and Indications to record self-weighing with a frequency of 2 times per week
Primary Outcome Measures
NameTimeMethod
Changes from baseline BMIAt baseline (0 years) and followed for 2 years

Baseline mean BMI values will be measured and compared at 3, 6, 12 and 24 months. BMI will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale

Changes from baseline Fatty massAt baseline (0 years) and followed for 2 years

Baseline mean Fatty mass values will be measured and compared at 3, 6, 12 and 24 months. Fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale. Fatty mass is measured as a percentage.

Changes from baseline Free-fatty massAt baseline (0 years) and followed for 2 years

Baseline mean Free-fatty mass values will be measured and compared at 3, 6, 12 and 24 months. Free-fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale. Fatty mass is measured as a percentage.

Changes from baseline Muscular MassAt baseline (0 years) and followed for 2 years

Baseline mean Muscular Mass values will be measured and compared at 3, 6, 12 and 24 months. Muscular Mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale. Fatty mass is measured as a Kg.

Changes from baseline Corporal WaterAt baseline (0 years) and followed for 2 years

Baseline mean Corporal Water values will be measured and compared at 3, 6, 12 and 24 months. Corporal Water will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale. Fatty mass is measured as a Kg.

Adherence to dietary pattern will be also measured through personal interviewAt baseline (0 years) and followed for 2 years

Participants will be subjected for an intervention based on nutritional (control group) and physical education (two intervention arms) during 24 months. Partial measures will be also taken every week. In the end of the trial, changes in dietary patterns will be measured comparing means differences between baselines, 3, 6, 12 and 24 months.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universidad de Córdoba

🇪🇸

Córdoba, Spain

© Copyright 2025. All Rights Reserved by MedPath